CIK: 0001082621 · Show all filings
Period: Q2 2021 (← Previous) (Next →)
Filing Date: Aug 13, 2021
Total Value ($000): $1,737,878 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| AAPL | APPLE INC | 2,434,903 | $333,484 | 19.2% | $126.45 | 0.0% | COM | 037833100 |
| RPRX | ROYALTY PHARMA PLC | 7,142,856 | $292,786 | 16.8% | $49.50 | -14.1% | SHS CLASS A | G7709Q104 |
| LNWO | SCIENTIFIC GAMES CORP | 2,678,571 | $207,429 | 11.9% | $21.43 | +186.6% | COM | 80874P109 |
| META | FACEBOOK INC | 519,456 | $180,620 | 10.4% | $260.88 | +22.1% | CL A | 30303M102 |
| PANW | PALO ALTO NETWORKS INC | 245,943 | $91,257 | 5.3% | $49.24 | +20.3% | COM | 697435105 |
| ABCL | ABCELLERA BIOLOGICS INC | 4,105,095 | $90,312 | 5.2% | $45.73 | -39.7% | COM | 00288U106 |
| ICE | INTERCONTINENTAL EXCHANGE IN | 688,549 | $81,731 | 4.7% | $106.46 | +1.7% | COM | 45866F104 |
| RXRX | RECURSION PHARMACEUTICALS IN | 1,509,254 | $55,088 | 3.2% | $29.60 | 0.0% | CL A | 75629V104 |
| DVA | DAVITA INC | 408,912 | $49,245 | 2.8% | $118.35 | 0.0% | COM | 23918K108 |
| TXG | 10X GENOMICS INC | 186,143 | $36,451 | 2.1% | $176.99 | +2.3% | CL A COM | 88025U109 |
| QQQ | INVESCO QQQ TR | 102,222 | $36,231 | 2.1% | $220.86 | — | UNIT SER 1 | 46090E103 |
| AFRM | AFFIRM HLDGS INC | 477,421 | $32,154 | 1.9% | $63.78 | 0.0% | COM CL A | 00827B106 |
| IVV | ISHARES TR | 65,342 | $28,092 | 1.6% | $181.43 | — | CORE S&P500 ETF | 464287200 |
| PCT | PURECYCLE TECHNOLOGIES INC | 1,069,600 | $25,296 | 1.5% | $22.89 | -6.0% | COM | 74623V103 |
| RVMD | REVOLUTION MEDICINES INC | 670,382 | $21,278 | 1.2% | $27.68 | +26.1% | COM | 76155X100 |
| U | UNITY SOFTWARE INC | 186,396 | $20,472 | 1.2% | $123.17 | -20.2% | COM | 91332U101 |
| RLAY | RELAY THERAPEUTICS INC | 541,124 | $19,800 | 1.1% | $38.13 | -13.6% | COM | 75943R102 |
| PLRX | PLIANT THERAPEUTICS INC | 562,379 | $16,376 | 0.9% | $26.54 | +17.3% | COM | 729139105 |
| GLD | SPDR GOLD TR | 91,955 | $15,231 | 0.9% | $126.45 | — | GOLD SHS | 78463V107 |
| — | PRAXIS PRECISION MEDICINES I | 778,517 | $14,231 | 0.8% | $55.02 | — | COM | 74006W108 |
| — | GENERATION BIO CO | 512,349 | $13,782 | 0.8% | $21.21 | — | COM | 37148K100 |
| — | KINNATE BIOPHARMA INC | 498,001 | $11,593 | 0.7% | $39.78 | — | COM | 49705R105 |
| SANA | SANA BIOTECHNOLOGY INC | 468,749 | $9,216 | 0.5% | $32.56 | -30.4% | COM | 799566104 |
| VEA | VANGUARD TAX-MANAGED INTL FD | 162,699 | $8,382 | 0.5% | $35.96 | — | FTSE DEV MKT ETF | 921943858 |
| NRIX | NURIX THERAPEUTICS INC | 314,762 | $8,351 | 0.5% | $25.20 | +16.5% | COM | 67080M103 |
| IJR | ISHARES TR | 50,474 | $5,703 | 0.3% | $70.20 | — | CORE S&P SCP ETF | 464287804 |
| FULC | FULCRUM THERAPEUTICS INC | 410,714 | $4,304 | 0.2% | $11.06 | -8.6% | COM | 359616109 |
| VWO | VANGUARD INTL EQUITY INDEX F | 73,804 | $4,008 | 0.2% | $46.05 | — | FTSE EMR MKT ETF | 922042858 |
| — | FS DEVELOPMENT CORP II | 400,000 | $4,000 | 0.2% | $9.96 | — | COM CL A | 30318F100 |
| IJH | ISHARES TR | 12,683 | $3,408 | 0.2% | $125.72 | — | CORE S&P MCP ETF | 464287507 |
| — | MAGENTA THERAPEUTICS INC | 332,610 | $3,253 | 0.2% | $12.01 | — | COM | 55910K108 |
| PDD | PINDUODUO INC | 25,493 | $3,238 | 0.2% | $133.89 | — | SPONSORED ADS | 722304102 |
| — | SERES THERAPEUTICS INC | 131,847 | $3,145 | 0.2% | $24.50 | — | COM | 81750R102 |
| — | DECIBEL THERAPEUTICS INC | 328,798 | $2,828 | 0.2% | $11.36 | — | COM | 24343R106 |
| DYN | DYNE THERAPEUTICS INC | 107,252 | $2,257 | 0.1% | $21.96 | -14.4% | COM | 26818M108 |
| — | GEMINI THERAPEUTICS INC | 250,000 | $1,618 | 0.1% | $13.55 | — | COM | 36870G105 |
| — | NUCANA PLC | 387,124 | $1,072 | 0.1% | $5.93 | — | SPONSORED ADR | 67022C106 |
| QNCX | CORTEXYME INC | 2,937 | $156 | 0.0% | $41.93 | 0.0% | COM | 22053A107 |